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mouse models with MPO-ANCA production. BALB/c mice were
given intraperitoneal (i.p.) injection of PMA (50 ng at day 0 and
day 7) and oral administration of PTU (5 mg/day) for 2 weeks. In
this model, MPO-ANCA was produced by day 14 though an
obvious vasculitic phenotype was not observed. These mice were
divided into two groups, namely Group 1 with daily i.p. injection
of Cl-amidine (0.3 mg/200 ml/day) (n¼7) and Group 2 with daily
i.p. injection of PBS (200 ml/day) (n¼13). Two weeks later, serum
MPO-ANCA titers and amounts of peritoneal NETs were compared
between the 2 groups.
Results: In vitro NET formation induced by 20 nM PMA with or
without 20 mM PTU was inhibited signiﬁcantly by 200 mM Cl-
amidine. Serum MPO-ANCA titers of Group 1 mice (32.3  31.0 ng/
ml) were signiﬁcantly lower than those of Group 2 mice (132.1 
41.6 ng/ml). The amounts of peritoneal NETs in Group 1 mice was
signiﬁcantly smaller than those in Group 2 mice. These ﬁndings
suggested that the NET formation was inhibited signiﬁcantly by Cl-
amidine both in vitro and in vivo, and that the MPO- ANCA
production was also suppressed by Cl-amidine in vivo.
Conclusions: PAD4 inhibitor suppresses MPO-ANCA production
through inhibition of NET formation in mouse model so that it
could be a novel therapeutic modality for MPO-AAV in humans.
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Introduction: Recent research has implicated that inﬂammation may
be a key pathophysiological mechanism in diabetic nephropathy
(DN), although its pathogenesis is multifactorial. Intercellular
adhesion molecule 1 (ICAM-1) is an acute phase marker of inﬂam-
mation and the ICAM-1 gene is located on chromosome 19p13.2 and
resides a linkage region to diabetes and DN. To investigate whether
ICAM-1 has effects in the development of DN, we have recently
performed genetic and pathological studies of this molecule in
Swedish and Malaysian subjects with normal glucose tolerance
(NGT), diabetes and DN.
Methods: We genotyped six single nucleotide polymorphisms
(SNPs) in the ICAM-1 gene with TaqMan allelic discrimination. We
also determined plasma ICAM-1 levels with an enzyme-linked im-
mune-sorbent assay kit.
Results: We found that non-synonymous SNP rs5498 (K469E A/G)
was associated diabetes and DN and the G allele had a protective
effect. Particularly, we found a high heterozygous index of this
polymorphism presenting in both populations. The genotype dis-
tribution of this polymorphism was kept in Hardy-Weinberg
Equilibrium and no duplicon in the genomic sequence was found.
The ICAM-1 K469E(A/G) polymorphism resides in the 5th Ig-like
domain of ICAM-1 protein. This domain is essential for dimeriza-
tion, surface presentation and solubilisation of proteins of the
protein and subsequently plays a crucial role in the activity of
ICAM-1 protein in the interaction with LFA-1 and the adhesion of B
cells. Furthermore, we found the carriers with heterozygous ge-
notype had higher fasting glucose levels among newly diagnosed
type 2 diabetes patients compared with the subjects with wild orS8mutant homozygous genotype. Plasma ICAM-1 levels were
increased from the subjects with NGT, diabetes without DN to the
patients with DN. Among diabetic patients with DN, the carriers
with heterozygous genotype had higher plasma ICAM-1 levels
compared with other patients.
Conclusions: Our study provided evidence that ICAM-1 has effects
in the development of DN. The patients carrying with heterozygous
genotype of SNP rs5498 (K469E A/G) in the ICAM-1 gene have
higher risk susceptibility to DN. The combined approach with
genotyping this polymorphism and measuring plasma ICAM-1
levels may be useful for prediction of DN in translation medicine.
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Introduction: Acute tubular necrosis (ATN) is common in severe
acute kidney injury (AKI). Inﬁltrating neutrophils contribute to the
crescendo of renal inﬂammation and kidney injury (necroin-
ﬂammation), but how neutrophils contribute to ATN is not clear.
We hypothesized that inﬁltrating neutrophils release neutrophil
extracellular traps (NETs), which implies the release of cytotoxic
DAMPs like histones that accelerate ATN and AKI.
Methods: In vivo; Postischemic AKI was induced in wild type mice
by unilateral clamping of the renal pedicle for 35 minutes followed
by reperfusion for 6h or 72h. Formation of NETs was identiﬁed by
immunostaining using citrullinated histone 3 (CitH3) antibody.
Intravascular NETs were conﬁrmed by neutrophil elastase (NE)-
DNA complex ELISA in plasma. Renalcell death was evaluated in
kidney sections by Tunel staining and PicoGreen DNA assay of
plasma. To investigate the effect of NETs inhibition in bilateral IRI
(ischemic 35min, reperfusion 24h) group of mice were treated with
either PAD inhibitor (PADin) or neutrophil depletion and sacriﬁced
24h after reperfusion. In vitro; To investigate whether hypoxia can
directly induce NETs formation or indirectly via hypoxia-induced
tubular cell death, 1) human neutrophils were incubated in 1% or
20%O2 for 24h, 2) the media of tubular cell line (TC), which were
incubated in 1% or 20%O2 for 24h, and stimulated with neutro-
phils for 4h. Furthermore, PMA or histone- induced NETs were
treated by PADin, anti-histone antibody and heparin. Histone-
stimulated neutrophil media were applied to TC. NETs and TC
injury in vitro were evaluated by CitH3 staining/MPO-DNA com-
plex and LDH assay, respectively.
Results: IRI kidney showed increased positivity for CitH3 in areas
of tubular necrosis of the outer medulla. Plasma levels of the NE-
DNA complex were increased in a time-dependent manner as
compared to sham-operated mice. NET-induced renal cell death was
shown in terms of increased Tunel positive area in kidney and
plasma DNA 6h after reperfusion compared to the sham group.
Subsequently, NETs in plasma and kidney increased 15w24h after
reperfusion. In bilateral IRI, treatment with both PADin and
neutrophil depletion signiﬁcantly reduced the plasma levels of NE-
DNA complex and NETs area in kidney compared to the vehicle
group. Treatment further improved renal excretory function in
terms of reducing plasma creatinine levels. In vitro, the NET-Kidney International Reports (2016) 1, S1–S22
